Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon for Neuroprotection in Aneurysmal Subarachnoid Hemorrhage
NCT04696523Phase 2Recruiting
- Sponsor
- Turku University Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of xenon in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Turku University Hospital. Started Apr 2025; status: recruiting.
02
Drugs
xenon
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT04696523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04696523.